Proprietary Name: Flexbumin® 

Common Name: Albumin (Human)

PDL Category: ELECTROLYTES

Indications and Usage: Hypovolemia, Hypoalbuminemia (general, burns, adult respiratory distress syndrome, or nephrosis), Cardiopulmonary Bypass Surgery, Hemolytic Disease of the Newborn

Dosage Forms: 20, 50, and 100mL single dose Galaxy plastic container for IV administration

Recommended Dosage: Hypovolemic Shock: 100-200mL for adults, 2.5-5 ml/kg for children. May repeat after 15-30 minutes if response is not adequate. Burns: administered after the first 24 hours following burn; dose should be determined according to the patient's condition and response to treatment. Hypoalbuminemia: Daily dose should not exceed 2 mg of albumin per kg of body weight. Hemolytic Disease of the Newborn: administer prior to or during exchange transfusion in a dose of 1gm/kg. 

Common Adverse Drug Reactions: Nausea, fever, chills, urticaria.

Contraindications: A history of allergic reactions to albumin, severely anemic patients, patients with cardiac failure

Manufacturer: Baxter

Analysis: Flexbumin® is the first human serum albumin preparation packaged in a flexible container (previously packaged in glass bottles). Flexbumin® is indicated in hypovolemia, hypoalbuminemia due to inadequate reproduction, excessive catabolism, hemorrhage, major surgery or burns, and for use during cardiopulmonary bypass surgery.

IME Recommendation:

Preferred Drug

Recommended Drug

Non-Preferred Drug

Non-Recommended Drug

Preferred Drug with Conditions